Kimura et al. [12] firstly observed that 80% of children with SJIA-LD developed pulmonary disease after 2004, following the spread of biological drugs (especially IL-1 inhibitors) for the treatment of sJIA. This evidence concerns the gene IL1B and lung disorder.